Valuation: XtalPi Holdings Limited

Capitalization	36.92B 40.71B 5.23B 4.45B 4.16B 3.9B 7.21B 472B 7.85B 48.41B 18.81B 223B 19.63B 19.21B 812B	P/E ratio 2025 *	-61.6x	P/E ratio 2026 *	-77.2x
Enterprise value	36.16B 39.87B 5.12B 4.36B 4.07B 3.82B 7.06B 462B 7.69B 47.42B 18.42B 218B 19.23B 18.82B 795B	EV / Sales 2025 *	68.2x	EV / Sales 2026 *	48.7x
Free-Float	39.22%	Yield 2025 *	-	Yield 2026 *	-

More valuation ratios * Estimated data

Chart: XtalPi Holdings Limited

Timeframe

Style

Dynamic Chart

Latest news: XtalPi Holdings Limited

10/11	XtalPi Holdings Limited Develops and Values Two Innovative Topical Efficacy Ingredients for Hair Loss Prevention and Hair Growth	CI
05/11	XtalPi Unit Enters Collab Contract for Bispecific Antibody Discovery, Development	MT
05/11	XtalPi's unit in strategic collaboration with Lilly to advance bispecific antibody development	RE
05/11	Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development	CI
09/09	Xtalpi Inc. Announces Pep08 Receives Regulatory Clearances to Initiate Phase 1 Clinical Trials in Solid Tumor	CI
09/09	XtalPi & PharmaEngine hit milestone as PRMT5 inhibitor PEP08 gets trial nod	RE
05/09	GoFintech Innovation Attracts Investments From Inkeverse, XtalPi; GoFintech Shares Up 3%	MT
04/09	XtalPi Raises HK$2.63 Billion from Share Placement	MT
29/08	XtalPi Eyeing HK$2.7 Billion via Share Sale	MT
28/08	XtalPi Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
27/08	XtalPi Turns to H1 Profit Amid 404% Revenue Boost	MT
20/08	XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies	CI
12/08	XtalPi to Swing to Profit in H1	MT

More news

News in other languages: XtalPi Holdings Limited

30/06

Pfizer : collaboration approfondie avec XtalPi dans l'IA

More news

Managers and Directors: XtalPi Holdings Limited

Manager	Title	Age	Since
Li Peng Lai PRN	Corporate Officer/Principal	41	01/01/2015
Jian Ma CEO	Chief Executive Officer	39	27/11/2023
Man Hong Tam DFI	Director of Finance/CFO	48	01/12/2020

Director	Title	Age	Since
Shu Hao Wen CHM	Chairman	44	27/11/2023
Jian Ma BRD	Director/Board Member	39	28/04/2017
Li Peng Lai BRD	Director/Board Member	41	28/04/2017

More insiders

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
XTALPI HOLDINGS LIMITED	-0.85%	-0.63%	+115.37%	-	5.23B
THERMO FISHER SCIENTIFIC, INC.	+0.89%	+0.64%	+8.34%	+3.33%	217B
INTUITIVE SURGICAL, INC.	-1.54%	-3.74%	+0.69%	+102.28%	194B
DANAHER CORPORATION	+0.85%	+2.31%	-1.29%	-13.73%	164B
BOSTON SCIENTIFIC CORPORATION	-1.02%	-6.11%	+1.31%	+98.46%	136B
SIEMENS HEALTHINEERS AG	+1.04%	+2.37%	-19.30%	-12.65%	57.2B
EDWARDS LIFESCIENCES CORPORATION	+0.38%	-1.80%	+14.13%	+13.82%	48.88B
AGILENT TECHNOLOGIES, INC.	-0.42%	-3.67%	+1.19%	-6.59%	40.44B
GE HEALTHCARE TECHNOLOGIES INC.	+1.87%	+4.28%	+3.99%	-	39.2B
RESMED, INC.	+0.35%	+0.35%	+2.69%	+14.89%	36.79B
Average	+0.38%	-0.20%	+12.71%	+24.98%	93.94B
Weighted average by Cap.	+0.39%	-1.01%	+2.56%	+35.69%

See all sector performances

XtalPi Holdings Ltd, formerly QuantumPharm Inc, is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. The drug discovery solutions business is engaged in providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The intelligent automation solutions business is engaged in the provision of solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.

Employees

1,054

Sector

Advanced Medical Equipment & Technology

Calendar

27/03 - Q4 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
12/12/25	9.380 $	-0.85%	33,309,000
11/12/25	9.460 $	-0.32%	42,134,500
10/12/25	9.490 $	+1.06%	34,867,800
09/12/25	9.390 $	-1.37%	37,122,000
08/12/25	9.520 $	+0.74%	61,860,170

Delayed Quote Hong Kong S.E., 12 December 2025 at 05:39 pm AEDT

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.460HKD

Average target price

10.12HKD

Spread / Average Target

+7.01%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed Hong Kong S.E. Other stock markets 05:39:17 12/12/25 pm AEDT			5-day change	1st Jan Change
9.380 ^HKD	-0.85%		-0.63%	+57.02%

1 day	-0.74%
1 week	-0.63%
Current month	-6.19%
1 month	-18.06%
3 months	-8.12%
6 months	+54.70%
Current year	+57.02%

1 week	9.23	9.76
1 month	8.84	11.65
Current year	3.85	15.12
1 year	3.05	15.12
3 years	3.05	16.2
5 years	3.05	16.2
10 years	3.05	16.2

	2025 *	2026 *
Net sales	530M 585M 75.12M 63.91M 59.67M 55.98M 104M 6.78B 113M 695M 270M 3.2B 282M 276M 11.66B	750M 827M 106M 90.39M 84.39M 79.17M 146M 9.58B 159M 983M 382M 4.53B 399M 390M 16.49B
Net income	-320M -353M -45.35M -38.58M -36.02M -33.79M -62.49M -4.09B -68.03M -420M -163M -1.93B -170M -167M -7.04B	-199M -219M -28.15M -23.95M -22.36M -20.98M -38.79M -2.54B -42.23M -261M -101M -1.2B -106M -103M -4.37B
Net Debt	-760M -837M -108M -91.56M -85.48M -80.2M -148M -9.71B -161M -996M -387M -4.59B -404M -395M -16.71B	-429M -473M -60.83M -51.76M -48.32M -45.33M -83.82M -5.49B -91.26M -563M -219M -2.59B -228M -223M -9.44B

XtalPi Holdings Limited Stock

Equities

2228

KYG7S12M1051